http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2330716-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2006-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d95b57d0271148fd6ec0f58c4fbc433 |
| publicationDate | 2009-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2330716-A1 |
| titleOfInvention | PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED PIRAZOLINE COMPOUNDS. |
| abstract | Pharmaceutical formulations of compounds ofnsubstituted pyrazoline.n n n The present invention relates to the use ofnsubstituted pyrazoline compounds characterized in that thenPharmaceutical formulation is in the selected form of: anosmotic actuated oral system for the release ofncompound, a parenteral implant, a multiporo tablet, angel matrix tabletn(Gel-Matrix-Tablet), a system ofntransdermal application, a parenteral deposit system, anoral formulation that uses taste masking agents with annatural flavor or a chewable formulation, preferably anbubble gum. |
| priorityDate | 2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 208.